Clinical Homecare
Specialist providers administering high-acuity treatments such as infusions, biologics and oncology therapies in the home setting
Clinical homecare strategy
Clinical Homecare: Expanding Access, Improving Outcomes
Clinical homecare enables patients to receive hospital-only medicines and nursing support in their own homes. While homecare models exist in parts of Europe and beyond, the UK has developed one of the largest and most mature markets globally, serving more than half a million patients each year, driven by NHS workforce limits and favourable VAT treatment. The scale alone makes this a significant growth opportunity, underpinned by advances in biologics and biosimilars, rising demand for specialist therapies, and the continued shift of care out of hospitals.
Patients benefit from convenience, safety, and improved adherence to treatment. Health systems reduce pressure on hospitals and clinical staff, while maintaining continuity of care. Pharmaceutical companies extend access to their medicines, strengthen patient engagement, and gain valuable insights into real-world outcomes.
We work with investors, providers, and pharmaceutical partners to unlock value in this complex and expanding market. Our expertise includes commercial due diligence and transaction support, post-acquisition value creation, and performance improvement. We also advise on go-to-market and pricing strategy, target operating model design, digital and AI-enabled data strategy, and commercial excellence. With a deep understanding of sector dynamics, we help clients capture growth while delivering better patient outcomes.
Our clinical homecare leads
Our teams combine scientific expertise with deal experience. We bring rigour to forecasting and valuation, assess regulatory and market access dynamics, and help frame development strategies that appeal to potential partners or acquirers. This ensures that investment cases are built on realistic assumptions and that transactions are structured to capture fair value.
Beyond transactions, we support operational priorities such as target operating model design, performance improvement, and digital and data strategy. By combining strategic clarity with an understanding of scientific and clinical realities, we help biotech firms and their backers make sound decisions in an increasingly competitive market.
News & Insights
Our healthcare Insights
News & Insights
Healthcare news, data and analysis
Via Investors in Healthcare
